skip navigation
    | | Text Size: -A | A | A+

    Picture of a female nurse talking to a female patient who is wearing the Cardea SOLO disposable wearable ECG sensor.

    W.J Mangold Memorial Hospital and Cogdell Clinics Adopt New Patient-Friendly Cardiac Digital Health Solution for Early AFib Detection and Diagnosis

    W.J. Mangold Memorial Hospital has integrated innovative wearable ECG technology from Cardiac Insight, Inc., expanding its offerings to patients to better diagnose atrial fibrillation (AFib or AF), the most common type of treated heart arrhythmia, both in-office and through telehealth. An estimated 2.7 to 6.1 million people in the U.S. live with this arrhythmia. While AFib itself is typically not life-threatening, complications from AFib include increased risk for heart problems and heart failure, and increased risk for stroke.

    The Cardea SOLO™ disposable wearable ECG sensor is applied to the patient at our Clinic. After a seven-day wear period, the patient returns the sensor to our office by mail or in person. Cardea SOLO's algorithm-based software automatically analyzes ECG data to detect abnormal rhythms including AFib. Within five minutes of connecting the patient's sensor to the Cardea SOLO, a comprehensive report is produced to direct clinical decision-making and begin treatment, if required, as soon as possible.

    For more information, please contact Elvia Holguin, Clinic Manager or make an appointment to see your primary care provider in Lockney at 806-652-3373 or Silverton at 806-475-5800.